Drugs@FDA: FDA-Approved Drugs
New Drug Application (NDA): 205103
Company: GENUS LIFESCIENCES
Company: GENUS LIFESCIENCES
Drug Name | Active Ingredients | Strength | Dosage Form/Route | Marketing Status | TE Code | RLD | RS |
---|---|---|---|---|---|---|---|
YOSPRALA | ASPIRIN; OMEPRAZOLE | 81MG;40MG | TABLET, DELAYED RELEASE;ORAL | Discontinued | None | Yes | No |
YOSPRALA | ASPIRIN; OMEPRAZOLE | 325MG;40MG | TABLET, DELAYED RELEASE;ORAL | Discontinued | None | Yes | No |
Original Approvals or Tentative Approvals
Action Date | Submission | Action Type | Submission Classification | Review Priority; Orphan Status | Letters, Reviews, Labels, Patient Package Insert | Notes | Url |
---|---|---|---|---|---|---|---|
09/14/2016 | ORIG-1 | Approval | Type 4 - New Combination | STANDARD |
Label (PDF)
Letter (PDF) Review |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205103s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/205103Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2016/205103Orig1s000TOC.cfm |
Supplements
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert | Note | Url |
---|---|---|---|---|---|
07/18/2023 | SUPPL-9 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205103s009lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/205103Orig1s009ltr.pdf | |
03/04/2022 | SUPPL-8 | Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205103s008lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/205103Orig1s008ltr.pdf | |
04/28/2021 | SUPPL-7 | Labeling-Package Insert, Labeling-Medication Guide |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205103s007lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/205103Orig1s007ltr.pdf | |
11/27/2020 | SUPPL-6 | Labeling-Medication Guide, Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205103s006lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/205103Orig1s006ltr.pdf | |
06/07/2018 | SUPPL-4 | Labeling-Package Insert, Labeling-Medication Guide |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205103s004lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/205103Orig1s004ltr.pdf | |
10/04/2017 | SUPPL-1 | Labeling-Medication Guide, Labeling-Package Insert |
Label (PDF)
Letter (PDF) |
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205103s001lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/205103Origs001ltr.pdf |
Action Date | Submission | Supplement Categories or Approval Type | Letters, Reviews, Labels, Patient Package Insert |
Note | Url |
---|---|---|---|---|---|
07/18/2023 | SUPPL-9 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/205103s009lbl.pdf | |
03/04/2022 | SUPPL-8 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/205103s008lbl.pdf | |
04/28/2021 | SUPPL-7 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205103s007lbl.pdf | |
04/28/2021 | SUPPL-7 | Labeling-Medication Guide | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/205103s007lbl.pdf | |
11/27/2020 | SUPPL-6 | Labeling-Medication Guide | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205103s006lbl.pdf | |
11/27/2020 | SUPPL-6 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2020/205103s006lbl.pdf | |
06/07/2018 | SUPPL-4 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205103s004lbl.pdf | |
06/07/2018 | SUPPL-4 | Labeling-Medication Guide | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/205103s004lbl.pdf | |
10/04/2017 | SUPPL-1 | Labeling-Medication Guide | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205103s001lbl.pdf | |
10/04/2017 | SUPPL-1 | Labeling-Package Insert | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/205103s001lbl.pdf | |
09/14/2016 | ORIG-1 | Approval | Label (PDF) | https://www.accessdata.fda.gov/drugsatfda_docs/label/2016/205103s000lbl.pdf |